227 related articles for article (PubMed ID: 9479530)
1. Might the refractive state in oculocutaneous albino patients be a clue for distinguishing between tyrosinase-positive and tyrosinase-negative forms of oculocutaneous albinism?
Käsmann B; Ruprecht KW
Ger J Ophthalmol; 1996 Nov; 5(6):422-7. PubMed ID: 9479530
[TBL] [Abstract][Full Text] [Related]
2. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
[TBL] [Abstract][Full Text] [Related]
3. [Human oculocutaneous albinism. From clinical observation to molecular biology].
Aquaron R
Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
[TBL] [Abstract][Full Text] [Related]
4. Albinism: its implications for refractive development.
Wildsoet CF; Oswald PJ; Clark S
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):1-7. PubMed ID: 10634592
[TBL] [Abstract][Full Text] [Related]
5. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
[TBL] [Abstract][Full Text] [Related]
6. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathway control and block location.
King RA; Olds DP
Am J Med Genet; 1985 Jan; 20(1):49-55. PubMed ID: 3918447
[TBL] [Abstract][Full Text] [Related]
7. [Eumelanin and pheomelanin contents in hairs of healthy Japanese and patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism].
Saito N; Morishima T
Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):853-61. PubMed ID: 2122048
[TBL] [Abstract][Full Text] [Related]
8. [Oculocutaneous albinism].
Lacour JP; Ortonne JP
Ann Pediatr (Paris); 1992 Sep; 39(7):409-18. PubMed ID: 1416662
[TBL] [Abstract][Full Text] [Related]
9. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
10. Refractive development in individuals with ocular and oculocutaneous albinism.
Verkicharla P; Thakur S; Kammari P; Dhakal R; Das AV
Int Ophthalmol; 2022 Jul; 42(7):2007-2015. PubMed ID: 35587842
[TBL] [Abstract][Full Text] [Related]
11. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
[TBL] [Abstract][Full Text] [Related]
12. Pigmented skin lesions in tyrosinase-positive oculocutaneous albinos: a study in black South Africans.
Bothwell JE
Int J Dermatol; 1997 Nov; 36(11):831-6. PubMed ID: 9427075
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of oculocutaneous albinism.
Spritz RA
Semin Dermatol; 1993 Sep; 12(3):167-72. PubMed ID: 8217557
[TBL] [Abstract][Full Text] [Related]
14. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
[TBL] [Abstract][Full Text] [Related]
16. [Genetics of oculocutaneous albinism].
Zühlke C; Stell A; Käsmann-Kellner B
Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
[TBL] [Abstract][Full Text] [Related]
17. The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids.
Kedda MA; Stevens G; Manga P; Viljoen C; Jenkins T; Ramsay M
Am J Hum Genet; 1994 Jun; 54(6):1078-84. PubMed ID: 8198130
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism by an electron microscopic dopa reaction test of fetal skin.
Shimizu H; Ishiko A; Kikuchi A; Akiyama M; Suzumori K; Nishikawa T
Prenat Diagn; 1994 Jun; 14(6):442-50. PubMed ID: 7937580
[TBL] [Abstract][Full Text] [Related]
19. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
Shimizu H
Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668
[TBL] [Abstract][Full Text] [Related]
20. Positive angle kappa: a sign of albinism in patients with congenital nystagmus.
Brodsky MC; Fray KJ
Am J Ophthalmol; 2004 Apr; 137(4):625-9. PubMed ID: 15059699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
